A predictive model for the clinical response to low dose ara‐<i>C</i>: a study of 102 patients with myelodysplastic syndromes or acute leukaemia
Eva Hellström‐Lindberg(Karolinska University Hospital), Åke Öst(Synlab Czech (Czechia)), Y. Kock(Karolinska University Hospital), Karl‐Henrik Robèrt(Blekinge Institute of Technology), Ann‐Mari Forsblom, Gösta Gahrton(Karolinska Institutet), Greger Lindberg(Karolinska Institutet)
Cited by 79
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
|PubMed|1991|765
World Gastroenterology Organisation Global Guideline
|Journal of Clinical Gastroenterology|2011|539